Highlights BELLUS Health

Equities

BLU

CA07987C2040

Delayed Toronto S.E. Other stock markets 04:00:00 2023-06-29 pm EDT			5-day change	1st Jan Change
19.48 ^CAD	-0.10%		-.--%	-.--%

2023	BELLUS Health Inc.(TSX:BLU) dropped from S&P/TSX Capped Composite Index	CI
2023	BELLUS Health Inc.(TSX:BLU) dropped from S&P/TSX Completion Index	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK completes acquisition of chronic cough-focused Bellus Health	23-06-28	AN
GSK Completes $2 Billion Acquisition of BELLUS Health	23-06-28	MT
GSK plc completed the acquisition of BELLUS Health Inc..	23-06-27	CI
BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition	23-05-16	MT
RBC Capital on Bellus Health	23-05-15	MT
BELLUS Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
BELLUS Health Q1 Loss Widens on Higher R&D Spending Ahead of US$2 Billion Sale to GSK	23-05-12	MT
BELLUS Health Brief: Bid Represented an approximate total equity value of US$2.0 billion and a premium of approximately 103%; transaction expected to close in Q3 2023	23-05-12	MT
BELLUS Health Brief: Comes After Co Announced agreement to be Acquired by GSK for US$14.75 per share of common stock in cash	23-05-12	MT
BELLUS Health Brief: For the quarter ended March 31, 2023, net loss amounted to US$25.1 million (US$0.20 per share	23-05-12	MT
North American Morning Briefing : Caution -2-	23-05-10	DJ
RBC Capital Markets Downgrades BELLUS Health After GSK Acquisition	23-04-19	MT
BELLUS Health Brief: Downgrading to Sector Perform From Outperform, Speculative Risk at RBC; Notes "Storm Before The CALM: GSK Swoops in for BLU, While CALM Pivotals Progress"	23-04-19	MT
Bellus Health Toronto-Listed Shares Double on GSK Takeover	23-04-18	DJ
BELLUS Health Brief: GSK Buying It For US$14.75 Per Share of Common Stock in Cash Representing a Near Total Equity Value of US$2.0 billion or 1.6 billion Pounds	23-04-18	MT
BELLUS Health Brief: Up Near 100% on TSX After GSK Reaches Agreement to Acquire It	23-04-18	MT
GSK Agrees to Buy BELLUS Health in US$2 Billion Deal	23-04-18	MT
BELLUS Health Brief: Buying It For US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion or 1.6 billion Pounds	23-04-18	MT
BELLUS Health Brief: Up Near 100% In US Pre-Market After GSK Reaches Agreement to Acquire It	23-04-18	MT
Trending : GSK Buys Bellus Health for About $2 Billion	23-04-18	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BELLUS Health

Equities

BLU

CA07987C2040

Highlights

Filters